Catalyst Pharmaceuticals announces ‘positive’ data from Firdapse trial
Catalyst Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare neuromuscular and neurological diseases announced positive...
FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review
EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, and Pfizer Inc. announced that the US FDA has...
PMV Pharma Secures $74 Million in Series B Financing for Cancer Drugs Targeting p53
PMV Pharmaceuticals, Inc., a leader in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer announced the completion of...
Apitope announces positive ATX-MS-1467 phase IIa data in relapsing Multiple Sclerosis
Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, announces positive results from the Phase IIa clinical...
CohBar, Inc. Announces Positive Results from Preclinical NASH Study of its Lead Drug Candidates
CohBar Inc , a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced that it has completed...
Vifor Pharma, ChemoCentryx Announce Expansion of Avacopan Agreement for Rare Renal Diseases
Vifor Pharma, a company of the Galenica Group, and ChemoCentryx, Inc. announced that Vifor Pharma has gained rights to commercialize avacopan in Asia, including Japan...
EC approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis
Eli Lilly and Company and Incyte Corporation announced that the EC has granted marketing authorisation for Olumiant® (baricitinib) 4 mg and 2 mg film-coated...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...